Article

The Nanomechanics of Neurotoxic Proteins Reveals Common Features at the Start of the Neurodegeneration Cascade

Biophysical Journal (impact factor: 3.65). 01/2012; 102(3):633a. pp.633a

ABSTRACT Amyloidogenic neurodegenerative diseases are incurable conditions caused by specific largely disordered proteins. However, the underlying molecular mechanism remains elusive. A favored hypothesis postulates that a critical conformational change in the monomer (an ideal therapeutic target) in these “neurotoxic proteins” triggers the pathogenic cascade. Using force spectroscopy with unequivocal single-molecule identification we demonstrate a rich conformational polymorphism at their monomer level. This polymorphism strongly correlates with amyloidogenesis and neurotoxicity: it is absent in a fibrillization-incompetent mutant, favored by familial-disease mutations and diminished by a surprisingly promiscuous inhibitor of the monomeric β-conformational change and neurodegeneration. The demonstrated ability to inhibit the conformational heterogeneity of these proteins by a single pharmacological agent reveals common features in the monomer and suggests a common pathway to diagnose, prevent, halt or reverse multiple neurodegenerative diseases.

0 0
 · 
0 Bookmarks
 · 
71 Views

Full-text (2 Sources)

View
16 Downloads
Available from
3 Dec 2012

Keywords

Amyloidogenic neurodegenerative diseases
 
conformational heterogeneity
 
critical conformational change
 
demonstrated ability
 
diagnose
 
favored hypothesis postulates
 
force spectroscopy
 
ideal therapeutic target
 
monomeric β-conformational change
 
polymorphism
 
promiscuous inhibitor
 
reverse multiple neurodegenerative diseases
 
rich conformational polymorphism
 
single pharmacological agent
 
specific
 
underlying molecular mechanism
 
unequivocal single-molecule identification
 
“neurotoxic proteins” triggers